Ildong Pharmaceutical Co., Ltd. 249420.KS Stock
Ildong Pharmaceutical Co., Ltd. Price Chart
Ildong Pharmaceutical Co., Ltd. 249420.KS Financial and Trading Overview
Ildong Pharmaceutical Co., Ltd. stock price | 14820 KRW |
Previous Close | 17320 KRW |
Open | 17340 KRW |
Bid | 17320 KRW x 0 |
Ask | 17330 KRW x 0 |
Day's Range | 17310 - 17670 KRW |
52 Week Range | 17100 - 60500 KRW |
Volume | 116.1K KRW |
Avg. Volume | 239.8K KRW |
Market Cap | 464.72B KRW |
Beta (5Y Monthly) | 1.149315 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 KRW |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | December 27, 2019 |
1y Target Est | N/A |
249420.KS Valuation Measures
Enterprise Value | 637.31B KRW |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.7446055 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 1.021 |
Enterprise Value/EBITDA | -12.95 |
Trading Information
Ildong Pharmaceutical Co., Ltd. Stock Price History
Beta (5Y Monthly) | 1.149315 |
52-Week Change | -51.95% |
S&P500 52-Week Change | 20.43% |
52 Week High | 60500 KRW |
52 Week Low | 17100 KRW |
50-Day Moving Average | 20473.8 KRW |
200-Day Moving Average | 27513.95 KRW |
249420.KS Share Statistics
Avg. Volume (3 month) | 239.8K KRW |
Avg. Daily Volume (10-Days) | 171.75K KRW |
Shares Outstanding | 26.79M |
Float | 15.93M |
Short Ratio | N/A |
% Held by Insiders | 40.81% |
% Held by Institutions | 3.54% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | N/A |
Trailing Annual Dividend Yield | N/A |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1.05:1 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -4.91% |
Operating Margin (ttm) | -12.65% |
Gross Margin | 36.96% |
EBITDA Margin | -7.88% |
Management Effectiveness
Return on Assets (ttm) | -7.23% |
Return on Equity (ttm) | -15.49% |
Income Statement
Revenue (ttm) | 624.12B KRW |
Revenue Per Share (ttm) | 23295.59 KRW |
Quarterly Revenue Growth (yoy) | -8.50% |
Gross Profit (ttm) | 236.14B KRW |
EBITDA | -49214066688 KRW |
Net Income Avi to Common (ttm) | -30654011392 KRW |
Diluted EPS (ttm) | N/A |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 61.32B KRW |
Total Cash Per Share (mrq) | 2289.45 KRW |
Total Debt (mrq) | 208.72B KRW |
Total Debt/Equity (mrq) | 108.54 KRW |
Current Ratio (mrq) | 0.846 |
Book Value Per Share (mrq) | N/A |
Cash Flow Statement
Operating Cash Flow (ttm) | -55437107200 KRW |
Levered Free Cash Flow (ttm) | -137865019392 KRW |
Profile of Ildong Pharmaceutical Co., Ltd.
Country | South Korea |
State | N/A |
City | Seoul |
Address | 2, Baumoe-ro 27-gil |
ZIP | N/A |
Phone | 82 2 526 3114 |
Website | https://www.ildong.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 1394 |
Ildong Pharmaceutical Co., Ltd. develops, manufactures, and sells pharmaceutical products in South Korea. The company offers active lactic acid bacterial and anti-diarrheal agents, antibiotics, antifungal and antiviral products, anti-histamine drugs, antineoplastic agents, and NSAIDs and analgesics, as well as vitamins, minerals, and nutrients; and drugs for blood circulation, cardiovascular and central nervous system, dental, endocrine and metabolic system, gastrointestinal system, respiratory system, topical preparation, and urogenital system applications. It also provides raw material drugs; health foods and foods; cosmetics; medical devices for scar treatment; and other drugs for treating thick wounds, osteoarthritis, periarthritis of shoulder, and artificial tears, as well as feminine cleanser products. In addition, the company manages licenses and provides contract manufacturing services. It also exports its products to approximately 20 countries worldwide. Ildong Pharmaceutical Co., Ltd. a strategic collaboration with Evotec SE to accelerate the development of various Ildong's proprietary projects through access to Evotec's INDiGO platform. The company was founded in 1941 and is headquartered in Seoul, South Korea.
Q&A For Ildong Pharmaceutical Co., Ltd. Stock
What is a current 249420.KS stock price?
Ildong Pharmaceutical Co., Ltd. 249420.KS stock price today per share is 14820 KRW.
How to purchase Ildong Pharmaceutical Co., Ltd. stock?
You can buy 249420.KS shares on the KSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ildong Pharmaceutical Co., Ltd.?
The stock symbol or ticker of Ildong Pharmaceutical Co., Ltd. is 249420.KS.
Which industry does the Ildong Pharmaceutical Co., Ltd. company belong to?
The Ildong Pharmaceutical Co., Ltd. industry is Drug Manufacturers-Specialty & Generic.
How many shares does Ildong Pharmaceutical Co., Ltd. have in circulation?
The max supply of Ildong Pharmaceutical Co., Ltd. shares is 28.04M.
What is Ildong Pharmaceutical Co., Ltd. Price to Earnings Ratio (PE Ratio)?
Ildong Pharmaceutical Co., Ltd. PE Ratio is now.
What was Ildong Pharmaceutical Co., Ltd. earnings per share over the trailing 12 months (TTM)?
Ildong Pharmaceutical Co., Ltd. EPS is 0 KRW over the trailing 12 months.
Which sector does the Ildong Pharmaceutical Co., Ltd. company belong to?
The Ildong Pharmaceutical Co., Ltd. sector is Healthcare.